Recent advancement of clinical immunoPET imaging in tumor diagnosis and therapy
10.3760/cma.j.cn321828-20200608-00225
- VernacularTitle:免疫PET显像在肿瘤诊疗中的研究进展
- Author:
Di ZHANG
1
;
Yumei CHEN
;
Haitao ZHAO
;
Cheng WANG
;
Weijun WEI
;
Jianjun LIU
Author Information
1. 上海交通大学医学院附属仁济医院核医学科，上海 200127
- Keywords:
Antibodies, monoclonal;
Antibodies;
Nanotechnology;
Positron-emission tomography;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2022;42(2):113-117
- CountryChina
- Language:Chinese
-
Abstract:
ImmunoPET imaging, which combining the specificity of monoclonal antibody and high sensitivity of PET imaging, blazes new trails of molecular imaging modality. In recent years, clinical translation and application of immunoPET imaging strategies have been flourishing, as a result, facilitating early and non-invasive diagnosis of numerous human tumors, patient stratification before monoclonal antibody therapy and radiation dose estimation prior to radioimmunotherapy. Here, we summarize the most recent clinical evidence of immunoPET in tumor diagnosis and therapy.
